Labiana Health S.A. (8RK)
FSX
Closed
Oct 8, 2026
Day's Range
5.4552 wk Range
3.88Overview - 8RK - Labiana Health S.A.
Key Statistics
Valuation
Enterprise Value
70.56M
P/E (Trailing)
‪16.11‬
Price / Sales (TTM)
‪0.64‬
Price / Book
‪7.12‬
EV / EBITDA
‪7.30‬
Profitability
Profit Margin
‪3.36%‬
Operating Margin
‪5.63%‬
Return on Assets
‪8.28%‬
Return on Equity
‪69.73%‬
Ownership
Shares Outstanding
7.16M
Held by Insiders
‪63.07%‬
Held by Institutions
‪9.69%‬
Price stats
Beta
‪0.15‬
50-Day Avg
‪6.13‬
200-Day Avg
‪5.65‬
Dividends
Payout Ratio
‪0.00%‬
Market Cap - 8RK - Labiana Health S.A.
Peers - 8RK - Labiana Health S.A.
Peer Comparison
Compared with companies in Drug Manufacturers - Specialty & Generic listed on FSX.
- 8RKFSXLabiana Health S.A.49.23MMarket Cap+28.62%52-week change16.11P/E (Trailing)‪3.36%‬Profit Margin
- ANLFSXAnalog Devices Inc.179.11BMarket Cap+43.92%52-week change47.10P/E (Trailing)‪29.78%‬Profit Margin
- PARFSXParker-Hannifin Corporation109.81BMarket Cap+26.04%52-week change35.40P/E (Trailing)‪16.96%‬Profit Margin
- MRKFSXMerck KGaA60.08BMarket Cap+13.03%52-week change25.79P/E (Trailing)‪11.21%‬Profit Margin
- MRKCFSXMerck KGaA – Sponsored ADR58.69BMarket Cap+14.60%52-week change24.77P/E (Trailing)‪11.21%‬Profit Margin
- PY3FSXGalderma Group AG39.87BMarket Cap-1.16%52-week change54.63P/E (Trailing)‪14.57%‬Profit Margin
- 0BOFSXJiangsu Hengrui Pharmaceuticals Co., Ltd.37.83BMarket Cap-75.44%52-week change37.67P/E (Trailing)‪24.93%‬Profit Margin
Profile Summary - 8RK - Labiana Health S.A.
About
Labiana Health S.A. is a Spain-based pharmaceutical holding company specializing in the development, manufacturing, and marketing of medicines for both animal and human health. It offers a diverse portfolio including anesthetics-sedatives, anti-infectives, anti-inflammatories, antiparasitics, hormonals, nutritional…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
